Friends
On my blog in my interview from iwCLL 2013, Professor Hallek discusses who should consider CIT (chemo-imminotherapy) and who should not. This is very important topic for anyone considering treatment.
Brian Koffman
Friends
On my blog in my interview from iwCLL 2013, Professor Hallek discusses who should consider CIT (chemo-imminotherapy) and who should not. This is very important topic for anyone considering treatment.
Brian Koffman
Thanks Brian, and a Healthy and Happy New Year to you.
Many thanks for these videos, please keep them coming.Best wishes